The CCRI will be designed to offer access to a network of core facilities and to provide its members with access to the requisite equipment, including the latest technologies and specialist expertise. This will be accomplished through in-house facilities, the local partner network and its international partner institutions. These cutting-edge facilities will enhance research and training and enable investigators to perform studies at the forefront of current research.
Besides the Founding Partners of the Institute, namely the UCY, the KF and the BOCOC, and its leading international partner, the Cambridge Stem Cell Institute (University of Cambridge), the Institute will actively seek collaboration with local and international academic and other institutions to broaden the depth and breadth of activities in basic, translational, clinical, and population research.
The Institute’s research groups will be supported by leading local teams (Cyprus Cancer Research Network) and CORE research facilities. Additionally, key international partner institutions will provide excellent training, research and funding opportunities. Collectively, these partner institutions will provide an outstanding environment for the promotion of interdisciplinary research in the area of cancer.
The Cyprus Cancer Research Network
In order to have a substantial impact on the prognosis, diagnosis, management and treatment of cancer, the CCRI will be in close collaboration with a number of national Clinical and Academic Centers, as well as Industrial Companies. The aim is to create a network of partners involving teams/ groups that already work on different aspects of cancer research and therapy in Cyprus. Combined with a diverse group of peers who share the same professional interests, our collaborative centers will enrich the way CCRI activities are designed, implemented and evaluated. The CCRI Network will enhance the opportunity to create a new translational and basic research culture, disseminate knowledge, improve the current understanding on cancer pathogenesis and eventually improve clinical practice by introducing effective and novel prevention and therapeutic approaches against different cancers.